1. DeeksSG, WalkerBD (2007) Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy. Immunity 27: 406–416.
2. SodoraDL, SilvestriG (2008) Immune activation and AIDS pathogenesis. AIDS 22: 439–446.
3. PaiardiniM, CervasiB, DunhamR, SumpterB, RadziewiczH, et al. (2004) Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res 29: 253–268.
4. CohenOJ, KinterA, FauciAS (1997) Host factors in the pathogenesis of HIV disease. Immunol Rev 159: 31–48.
5. CasadoC, ColomboS, RauchA, MartinezR, GunthardHF, et al. (2010) Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One 5: e11079.
6. CaoY, QinL, ZhangL, SafritJ, HoDD (1995) Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. N Engl J Med 332: 201–208.
7. HarrerT, HarrerE, KalamsSA, ElbeikT, StapransSI, et al. (1996) Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 12: 585–592.
8. PantaleoG, MenzoS, VaccarezzaM, GraziosiC, CohenOJ, et al. (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209–216.
9. DescoursB, Avettand-FenoelV, BlancC, SamriA, MelardA, et al. (2012) Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 54: 1495–1503.
10. MiguelesSA, ConnorsM (2010) Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA 304: 194–201.
11. PotterSJ, LacabaratzC, LambotteO, Perez-PatrigeonS, VingertB, et al. (2007) Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol 81: 13904–13915.
12. ElrefaeiM, McElroyMD, PreasCP, HohR, DeeksS, et al. (2004) Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 173: 2184–2189.
13. KlattNR, SilvestriG (2012) CD4+ T Cells and HIV: A Paradoxical Pas de Deux. Science Translational Medicine 4: 123ps124.
14. RotgerM, DalmauJ, RauchA, McLarenP, BosingerSE, et al. (2011) Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 121: 2391–2400.
15. ChoudharySK, VrisekoopN, JansenCA, OttoSA, SchuitemakerH, et al. (2007) Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 81: 8838–8842.
16. CurriuM, Fausther-BovendoH, PernasMa, MassanellaM, CarrilloJ, et al. (2012) Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function. PLoS One 7: e30330.
17. BallanaE, Ruiz-de AndresA, MotheB, Ramirez de ArellanoE, AguilarF, et al. (2012) Differential prevalence of the HLA-C – 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology 217: 889–894.
18. ShawJM, HuntPW, CritchfieldJW, McConnellDH, GarciaJC, et al. (2013) Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses 29: 172–177.
19. HerspergerAR, PereyraF, NasonM, DemersK, ShethP, et al. (2010) Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 6: e1000917.
20. KlattNR, SilvestriG, HirschV (2012) Nonpathogenic simian immunodeficiency virus infections. Cold Spring Harb Perspect Med 2: a007153.
21. KlattNR, ChomontN, DouekDC, DeeksSG (2013) Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 254: 326–342.
22. BuzonMJ, SunH, LiC, ShawA, SeissK, et al. (2014) HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med 20: 139–142.
23. LugliE, DominguezMH, GattinoniL, ChattopadhyayPK, BoltonDL, et al. (2013) Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest 123: 594–599.
24. CartwrightEK, McGaryCS, CervasiB, MicciL, LawsonB, et al. (2014) Divergent CD4+ T Memory Stem Cell Dynamics in Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections. J Immunol 192: 4666–4673.
25. PaiardiniM, CervasiB, Reyes-AvilesE, MicciL, OrtizAM, et al. (2011) Low levels of SIV infection in sooty mangabey central memory CD(4)(+) T cells are associated with limited CCR5 expression. Nat Med 17: 830–836.
26. HechtFM, BuschMP, RawalB, WebbM, RosenbergE, et al. (2002) Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16: 1119–1129.
27. GiorgiJV, HultinLE, McKeatingJA, JohnsonTD, OwensB, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859–870.
28. BrenchleyJM, HillBJ, AmbrozakDR, PriceDA, GuenagaFJ, et al. (2004) T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78: 1160–1168.
29. PatelVP, KreiderBL, LiY, LiH, LeungK, et al. (1997) Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 185: 1163–1172.
30. LeeYS, WonKJ, ParkSW, LeeHW, KimB, et al. (2012) Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2. Cell Immunol 279: 1–11.
31. SchreiberTH, PodackER (2013) Immunobiology of TNFSF15 and TNFRSF25. Immunol Res 57: 3–11.
32. JinJ, YuQ, HanC, HuX, XuS, et al. (2013) LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat Commun 4: 2075.
33. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
34. RodgerAJ, FoxZ, LundgrenJD, KullerLH, BoeseckeC, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200: 973–983.
35. LichtfussGF, HoyJ, RajasuriarR, KramskiM, CroweSM, et al. (2011) Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. Biomark Med 5: 171–186.
36. ChahroudiA, BosingerSE, VanderfordTH, PaiardiniM, SilvestriG (2012) Natural SIV hosts: showing AIDS the door. Science 335: 1188–1193.
37. ChomontN, El-FarM, AncutaP, TrautmannL, ProcopioFA, et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893–900.
38. DouekDC, BrenchleyJM, BettsMR, AmbrozakDR, HillBJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95–98.
39. GrovesKC, BibbyDF, ClarkDA, IsaksenA, DeaytonJR, et al. (2012) Disease Progression in HIV-1-Infected Viremic Controllers. J Acquir Immune Defic Syndr 61: 407–416.
40. McGaryCS, CervasiB, ChahroudiA, MicciL, TaaffeJ, et al. (2014) Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J Virol 88: 4533–4542.
41. SchindlerM, MunchJ, KutschO, LiH, SantiagoML, et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055–1067.
42. OkoyeA, Meier-SchellersheimM, BrenchleyJM, HagenSI, WalkerJM, et al. (2007) Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204: 2171–2185.
43. JanssenRS, SattenGA, StramerSL, RawalBD, O'BrienTR, et al. (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280: 42–48.
44. KotheD, ByersRH, CaudillSP, SattenGA, JanssenRS, et al. (2003) Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33: 625–634.
45. HatanoH, Vivek JainV, HuntP, LeeT, SinclairH, et al. (2013) Cell-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1 Expressing CD4+ T cells. J Infect Dis 208: 50–56.
46. KlattNR, VintonCL, LynchRM, CanaryLA, HoJ, et al. (2011) SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 118: 5803–5812.
47. BosingerSE, LiQ, GordonSN, KlattNR, DuanL, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. The Journal of Clinical Investigation 119: 3556–3572.